Related Experiment Video

Updated: May 11, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic function

Jian-Ping Guo1, Wei Tian, Shaokun Shu

  • 1Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital and Institute, Beijing, China.

Plos One
|May 22, 2013
PubMed

Insights

IKBKE regulates Forkhead box O (FOXO) transcription factors, specifically FOXO3a, through phosphorylation at Ser644. This leads to FOXO3a degradation and altered cellular localization, impacting cell survival and growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Forkhead box O (FOXO) transcription factors are crucial for cell survival and growth.
  • FOXO activity is regulated by post-translational modifications, affecting its localization and function.

Purpose of the Study:

  • To investigate the role of IKBKE in regulating FOXO3a.
  • To identify the specific mechanism by which IKBKE influences FOXO3a activity.

Main Methods:

  • Phosphorylation assays to detect FOXO3a modification at Ser644.
  • Western blotting to assess protein degradation and localization.
  • Analysis of tumor samples for IKBKE and pFOXO3a-S644 correlation.

Main Results:

  • IKBKE phosphorylates FOXO3a at Ser644, leading to its degradation and nuclear-cytoplasmic translocation.
  • IKBKE inhibits FOXO3a activity, even when key Akt phosphorylation sites are mutated.
  • Elevated pFOXO3a-S644 levels correlate with IKBKE overexpression in lung and breast tumors.

Conclusions:

  • IKBKE primarily regulates FOXO3a through phosphorylation of Ser644.
  • IKBKE influences cellular functions, at least partly, via FOXO3a regulation.
  • This interaction may play a role in lung and breast tumorigenesis.

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...